你可能会喜欢
Discover new insights in neuropsychiatric care at #ECNP2025. Prakash Masand, MD and Professor Charlotte Teunissen, PhD will review cholinergic mechanisms and unmet needs in schizophrenia and Alzheimer’s disease.
Driving innovation in prostate cancer therapy our scientists are focusing on new approaches for patients with advanced disease. This Prostate Cancer Awareness Month and beyond, we’re dedicated to tackling unmet needs and improving outcomes. bit.ly/4mW9Qk8 #ProstateCancer
Join us at #ERSCongress as we explore gaps in early #PulmonaryFibrosis diagnosis, disease burden and the current treatment paradigm and the role of lysophosphatidic acid (LPA-LPA1) in the disease and its clinical implications. Details below. bit.ly/4gI3cMO #OneBMS
We’re advancing targeted protein degradation with three powerful approaches: CELMoD agents, ligand-directed degraders and degrader antibody conjugates, to help address unmet needs in blood cancer and beyond: bit.ly/423mHcy #BloodCancerAwarenessMonth #OneBMS
Join us at #EADVCongress tomorrow as we delve into the future of psoriatic disease management and strategies for achieving optimal patient care. Details below. bit.ly/4niiVoo #OneBMS
Transforming treatment, CAR T cell therapy is helping redefine what’s possible in blood cancers and beyond. See how we’re driving the future of cell therapy: bit.ly/4gvBvqv #BloodCancerAwarenessMonth #ScienceFirsthand #OneBMS
We’re excited to introduce a new website built to centralize and elevate our scientific presence across global medical meetings. Explore now to gain access to our oral presentations, posters and future scientific content. bit.ly/465OStN #IMS25 #OneBMS
Join us tomorrow at #IMS25 for an in-depth exploration on the latest advancements in the treatment of #MultipleMyeloma, including clinical and real-world data on CAR T cell therapies, targeted protein degradation and more. Details below. bit.ly/4nnFyYB #OneBMS
Join us at #ISBD2025 for a comprehensive overview of bipolar disorder. Roger McIntyre, MD and Tadafumi Kato, MD, PhD, will explore potential role of muscarinic signaling in bipolar I disorder.
Join us at #PsychCongress2025 for a focused look into schizophrenia. Heather Luing, MD, and Desiree Matthews, PMHNP-BC, will explore the clinical biological complexity of schizophrenia.
#ECTRIMS2025 is a space for the scientific community to explore what may be next in #MultipleSclerosis. Join us at “Resetting Immunity: CAR T Cell Therapy in MS” w/ Prof. Gavin Giovannoni, Dr. Pavle Repovic & Dr. Claire Roddie, no registration required. bit.ly/3JVYm22
Tomorrow at #WCLC, Dr @VamsiVelcheti will present clinical and translational data on impact of MGF support during LAG-3 inhibition in combination with PD-1 inhibition and chemotherapy in NSCLC from RELATIVITY-104. Join the session at 1pm CEST in Room 06. #LCSM #lungcancer
Tomorrow at #WCLC, @DoctorJSpicer will present patient-reported outcomes with perioperative IO by nodal status in patients with resectable NSCLC from CheckMate 77T. Join the session at 12pm CEST in Room 01. #LCSM #lungcancer
Tomorrow at #WCLC, hear clinical results from CA240-0007, a Phase 1 trial of an MTA-cooperative PRMT5 inhibitor in NSCLC patients with homozygous 𝘔𝘛𝘈𝘗 deletion. Join the session at 12pm CEST in Room 02. #LCSM #lungcancer
Tomorrow at #WCLC, Dr @LuisPaz_Ares will present in the poster session overall survival with LAG-3 inhibition in combination with PD-1 inhibition and chemotherapy in metastatic NSCLC from RELATIVITY-104. #LCSM #lungcancer
Tomorrow at #WCLC, Dr Cho @cbcbc1971 will present long-term data from the Phase 1/2 TRIDENT-1 trial in patients with 𝘙𝘖𝘚1 fusion-positive NSCLC. Join the session at 12pm CEST in Room 02. #LCSM #lungcancer
Tomorrow at #WCLC, Dr @t_mitsudomi will present survival and health-related quality of life results with neoadjuvant chemoIO by surgical outcomes in CheckMate 816. Join the session at 12pm CEST in Room 06. #LCSM #lungcancer
Hematologic diseases are complex, requiring innovative treatment approaches. Learn how our R&D team is investigating potential new therapies for the treatment of multiple myeloma and lymphoma. bit.ly/4gaAtzU #BloodCancerAwarenessMonth
Join us ahead of #SOHO2025 as we discuss the impact of anemia on quality of life in patients with myelodysplastic syndromes and myeloproliferative neoplasms and more. Details below. #OneBMS bit.ly/4nauIoi
Gain practical insights into the diagnosis and management of HCM at #ESCCongress. Attend our in-depth tutorial on advanced imaging, risk stratification and real-world case reviews to enhance long-term care strategies: bit.ly/4lJUYVn #OneBMS
United States 趋势
- 1. phil 107K posts
- 2. Falcons 19.7K posts
- 3. Falcons 19.7K posts
- 4. Drake London 2,682 posts
- 5. phan 85.6K posts
- 6. Josh Allen 7,711 posts
- 7. Columbus 244K posts
- 8. Jorge Polanco 7,378 posts
- 9. Bijan 4,716 posts
- 10. Palmer 9,949 posts
- 11. Tyler Allgeier 1,193 posts
- 12. #BUFvsATL 1,866 posts
- 13. Mitch Garver N/A
- 14. Penix 2,357 posts
- 15. Starship 58.5K posts
- 16. #DirtyBirds 1,580 posts
- 17. #RiseUp N/A
- 18. Shakir 2,191 posts
- 19. Dawson Knox N/A
- 20. Mike Hughes N/A
你可能会喜欢
-
Sean Davis
@seanmdav -
Fortress Biotech
@fortressbio -
Allogene Therapeutics
@AllogeneTx -
Amgen Oncology
@AmgenOncology -
Lilly Medical US
@LillyMedical -
Novartis US
@NovartisUS -
Carl T 💪🏾💯👊🏽🕶🐶
@CTyroneD -
Novartis US Medical
@NovartisUSMed -
JCharlesAssets 🌊
@JCharlesAssets -
Pfizer Oncology Medical
@PfizerOncMed -
NetSmartz
@NetSmartz -
VacationRenter
@VacationRenter_ -
Stefano Crippa
@StefanoCrippa6 -
UCB US
@UCBUSA -
McCormick Corporate
@McCormickCorp
Something went wrong.
Something went wrong.